GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » AroCell AB (OSTO:AROC) » Definitions » Total Equity

AroCell AB (OSTO:AROC) Total Equity : kr121.20 Mil (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is AroCell AB Total Equity?

AroCell AB's total equity for the quarter that ended in Dec. 2024 was kr121.20 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

AroCell AB Total Equity Historical Data

The historical data trend for AroCell AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AroCell AB Total Equity Chart

AroCell AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.26 217.45 222.69 163.65 121.20

AroCell AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 163.65 153.14 140.05 130.21 121.20

AroCell AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

AroCell AB's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=134.126-12.928
=121.20

AroCell AB's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=134.126-12.928
=121.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AroCell AB Total Equity Related Terms

Thank you for viewing the detailed overview of AroCell AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AroCell AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » AroCell AB (OSTO:AROC) » Definitions » Total Equity
Comparable Companies
OSTO:SENZA NGM:LUMITO OSTO:IMMNOV XSAT:GEAN NGM:LEVBIO NGM:ATANA OSTO:PROGEN XSAT:SPERM TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT DGX LH
Traded in Other Exchanges
80R:Germany
Address
Uppsala Business Park, Virdings alle 32 B, Uppsala, SWE, 754 50
Website
https://www.arocell.com
AroCell AB is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden.